Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of add-on Canagliflozin in Patients With Type 2 Diabetes Treated With ≥200 Units Per Day of U-500 Insulin

NCT02597309 is registered in ClinicalTrials.gov with Joslin Diabetes Center as lead sponsor.

NCT NCT02597309
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02597309 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of add-on Canagliflozin in Patients With Type 2 Diabetes Treated With ≥200 Units Per Day of U-500 Insulin
Lead sponsor
Joslin Diabetes Center
Phase
Phase 4
Overall status
Withdrawn
Start date
November 30, 2015
Completion date
July 31, 2017
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, obesity